The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Vascular Endothelial Growth Factor Vegf
The Vascular Endothelial Growth Factor (Vegf) test contains 1 test with 1 biomarker.
Brief Description: The Vascular Endothelial Growth Factor (VEGF) test is a laboratory test that measures the levels of VEGF in the blood. VEGF is a protein that plays a crucial role in angiogenesis, which is the process of new blood vessel formation. Produced by a variety of cells, VEGF can stimulate vascular endothelial cells to grow, migrate, and form new blood vessels.
Collection Method: Blood Draw
Specimen Type: Plasma
Test Preparation: No preparation required
Healthcare providers might order the VEGF test in specific contexts:
Cancer Diagnosis and Treatment: Some tumors can produce and release VEGF to promote the growth of new blood vessels, which provide the tumor with nutrients and oxygen. By measuring VEGF levels, doctors can assess the tumor's ability to grow and spread.
Eye Diseases: Conditions like wet age-related macular degeneration (wet AMD) and diabetic retinopathy involve abnormal blood vessel growth in the eyes. VEGF levels might be evaluated in the context of these diseases.
Research Purposes: VEGF testing is also commonly used in research settings to understand its role in various diseases and to evaluate the efficacy of anti-VEGF treatments.
The VEGF test determines the concentration of Vascular Endothelial Growth Factor in the blood. Elevated levels may indicate an active process of angiogenesis or conditions that stimulate the production of this growth factor.
When a VEGF test is ordered, it's often part of a broader evaluation of these conditions. Here are some tests commonly ordered alongside it:
Complete Blood Count (CBC) with Differential:
Tumor Markers (such as CA-125, CEA, PSA, depending on the suspected cancer):
C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR):
These tests, when ordered alongside a VEGF test, provide a comprehensive evaluation of conditions associated with abnormal blood vessel growth, such as cancer or age-related macular degeneration. They help in diagnosing these conditions, understanding their severity, monitoring treatment response, and guiding management strategies. The specific combination of tests will depend on the individual’s symptoms, clinical presentation, and suspected condition.
The main conditions that could warrant a VEGF test include:
Various Cancers: Particularly those known for robust angiogenesis, like renal cell carcinoma or certain brain tumors.
Wet Age-Related Macular Degeneration: An eye condition characterized by abnormal blood vessel growth in the macula, the part of the retina responsible for central vision.
Diabetic Retinopathy: A complication of diabetes that affects the eyes, leading to abnormal blood vessel formation.
Rheumatoid Arthritis: Some studies suggest VEGF plays a role in the angiogenesis seen in the inflamed joints of people with rheumatoid arthritis.
VEGF test results can offer valuable insights:
Diagnosis: Elevated VEGF levels can suggest active angiogenesis due to conditions like cancer or wet AMD.
Treatment Monitoring: If a patient is receiving anti-VEGF therapy (like bevacizumab for certain cancers or eye conditions), periodic testing can help monitor the treatment's effectiveness.
Prognostication: In certain cancers, very high VEGF levels might indicate a more aggressive disease with a poorer prognosis.
The interpretation of VEGF levels should always be done in the context of clinical findings, other lab results, and imaging studies.
Why is the Vascular Endothelial Growth Factor (VEGF) test ordered?
The VEGF test is typically ordered to assess the levels of VEGF in the blood. VEGF plays a pivotal role in angiogenesis, the process of new blood vessel formation. Monitoring VEGF levels can be crucial in patients with certain types of cancers, as tumors often release VEGF to promote blood vessel growth and enhance their supply of nutrients.
What conditions can the VEGF test help detect or monitor?
The VEGF test can help detect or monitor conditions related to abnormal blood vessel formation. This includes certain cancers, especially those known to have increased angiogenesis, such as malignant melanoma, colorectal cancer, and breast cancer. Elevated VEGF levels may also be observed in conditions like rheumatoid arthritis and other inflammatory diseases.
What do elevated levels of VEGF indicate?
Elevated levels of VEGF can suggest increased angiogenesis. In the context of cancer, this could mean the tumor is trying to secure a greater blood supply to support its growth. Outside of cancer, high VEGF levels might indicate an inflammatory process or other conditions that stimulate new blood vessel formation.
Are there benign reasons for increased VEGF levels?
Yes, VEGF levels can be elevated due to non-malignant conditions, including wound healing, certain infections, or chronic inflammatory diseases.
How can the results from the Vascular Endothelial Growth Factor (VEGF) test influence treatment decisions?
In cancer patients, elevated VEGF levels might prompt a consideration for anti-angiogenic therapies, which target the blood vessels supplying the tumor. These treatments aim to "starve" the tumor by inhibiting its blood supply. Regular monitoring of VEGF levels can also give insights into how well the therapy is working.
Why is monitoring VEGF levels important in patients undergoing anti-angiogenic therapy?
Monitoring VEGF levels can offer insights into the effectiveness of anti-angiogenic therapy. A significant reduction in VEGF levels post-treatment might suggest the therapy is effective, while persistent high levels could indicate resistance to the therapy or its failure.
Does the Vascular Endothelial Growth Factor (VEGF) test replace other diagnostic tools for cancer?
No, the VEGF test is typically used in conjunction with other diagnostic and monitoring tools. While it provides valuable information about angiogenesis, it's just one piece of the larger diagnostic puzzle.
How frequently should the VEGF test be done in cancer patients?
The frequency depends on the specific clinical scenario, the type of cancer, and the treatments being used. For patients on anti-angiogenic therapies, periodic testing might be done to assess the therapy's efficacy and adjust treatment plans accordingly.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.